nicotine has been researched along with neuropeptide y in 51 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (7.84) | 18.7374 |
| 1990's | 17 (33.33) | 18.2507 |
| 2000's | 16 (31.37) | 29.6817 |
| 2010's | 12 (23.53) | 24.3611 |
| 2020's | 2 (3.92) | 2.80 |
| Authors | Studies |
|---|---|
| Dalsgaard, CJ; Franco-Cereceda, A; Rydh, M | 2 |
| Cervin, A; Lindberg, S; Mercke, U; Uddman, R | 1 |
| Brenn, T; Haass, M; Richardt, G; Schömig, A; Schömig, E | 1 |
| Franco-Cereceda, A; Lou, YP; Lundberg, JM | 1 |
| Fischer-Colbrie, R; Fleming, PJ; Höfle, G; Hogue-Angeletti, R; Humpel, C; Laslop, A; Saria, A; Weiler, R; Winkler, H; Wohlfarter, T | 1 |
| Franco-Cereceda, A; Lundberg, JM; Saria, A | 1 |
| Hexum, TD; Russett, LR | 1 |
| Haass, M; Hock, M; Lang, RE; Neeb, S; Richardt, G; Schömig, A | 1 |
| Costa, E; Higuchi, H; Yang, HY | 1 |
| Hiremagalur, B; Sabban, EL | 1 |
| Bek, M; Illes, P; Limberger, N; Nörenberg, W; Takeda, K | 1 |
| Duran, K; Garcia, B; Ortega, W; Priola, DV | 1 |
| DiMaggio, DA; Farah, JM; Westfall, TC | 1 |
| McComb, RD; Pfeiffer, RF; Shen, GH; Shimoda, K; Yang, HY | 1 |
| Gerber, S; Haass, M; Haunstetter, A; Kaufmann, A; Krüger, C; Kübler, W; Serf, C | 1 |
| Bing, C; Dryden, S; Frankish, HM; MacFarlane, IA; Wang, Q; Williams, G | 1 |
| Houpt, TA; Jahng, JW; Joh, TH; Wessel, TC | 1 |
| Matta, SG; Sharp, BM; Valentine, JD | 1 |
| Chen, X; Han, S; Naes, L; Westfall, T; Wu, YM | 1 |
| Hexum, TD; Zhang, P; Zheng, J | 1 |
| Wang, R; Wang, Z | 1 |
| Kane, JK; Li, MD; Matta, SG; McAllen, K; Parker, SL; Sharp, BM | 1 |
| Brogan, RS; Grove, KL; Keller, JA; Sekhon, HS; Smith, MS; Spindel, ER | 1 |
| Brunner, HR; Cavadas, C; Cotrim, MD; Grouzmann, E; Mosimann, F; Ribeiro, CA; Silva, AP | 1 |
| Bishop, C; Coscina, DV; Parker, GC | 1 |
| Brunner, HR; Cavadas, C; Cotrim, Md; Grouzmann, E; Mosimann, F; Ribeiro, CA | 1 |
| Bahn, GH; Cho, SY; Jang, MH; Kim, CJ; Kim, EH; Kim, KH; Shin, MC | 1 |
| Hexum, TD; Zheng, J; Zhou, G | 1 |
| Anderson, GP; Bozinovski, S; Chen, H; Jones, J; Morris, MJ; Vlahos, R | 1 |
| Ehlers, CL; El Khoury, A; Mathé, AA; Slawecki, CJ; Thorsell, AK | 1 |
| Mahapatra, NR; Mahata, M; Mahata, SK; O'Connor, DT | 1 |
| Fornari, A; Lippi, G; Pedrazzi, P; Picciotto, MR; Zini, I; Zoli, M | 1 |
| Huang, LZ; Winzer-Serhan, UH | 1 |
| Chae, Y; Hahm, DH; Han, JH; Lee, H; Lee, HS; Park, HJ; Shim, I; Yeom, M | 1 |
| Boissoneault, J; Bruijnzeel, AW; Isaac, S; Prado, M; Rylkova, D; Shah, HP | 1 |
| Dandekar, MP; Kokare, DM; Nakhate, KT; Subhedar, NK | 1 |
| Aydin, C; Isgor, C; Oztan, O | 3 |
| Huang, H; van den Pol, AN; Xu, Y | 1 |
| Kokare, DM; Nakhate, KT; Rangani, RJ; Subhedar, NK; Upadhya, MA | 1 |
| Diéguez, C; Fernø, J; López, M; Martínez de Morentin, PB; Nogueiras, R; Vidal-Puig, A; Whittle, AJ | 1 |
| Carneiro-de-Oliveira, PE; Cruz, FC; Leão, RM; Planeta, CS; Rossetto, DB; Valentini, SR; Zanelli, CF | 1 |
| Abagyan, A; Funkelstein, L; Hook, V; Mosier, C; Toneff, T; Ziegler, M | 1 |
| Kokare, DM; Kotagale, NR; Shelkar, GP; Taksande, BG; Umekar, MJ; Walke, S | 1 |
| Ambrósio, AF; Baptista, S; Gonçalves, J; Martins, J; Silva, AP | 1 |
| Arduini, I; Clark, KL; Horn, JP; Kullmann, PH; Sikora, KM; Springer, MG | 1 |
| Hu, T; Li, MD; Yang, Z | 1 |
| Aotani, D; Guo, T; Inagaki, N; Iwakura, H; Kaneko, K; Kusakabe, T; Masuzaki, H; Matsumoto, M; Minokoshi, Y; Miyazawa, T; Nakao, K; Ogino, Y; Sawamoto, K; Tanaka, T; Unzai, T | 1 |
| Aypar, B; Balkan, B; Birdogan, A; Gokmen, RC; Gozen, O; Kanit, L; Keser, A; Koylu, EO; Ozturk Bintepe, M; Salur, E; Tuzcu, F | 1 |
2 review(s) available for nicotine and neuropeptide y
| Article | Year |
|---|---|
Effects of drugs of abuse on the central neuropeptide Y system.
Topics: Amphetamines; Animals; Brain; Cocaine; Disease Models, Animal; Ethanol; Mice; Neuropeptide Y; Nicotine; Opiate Alkaloids; Rats; Receptors, Neuropeptide Y | 2016 |
Pharmacological Effects and Regulatory Mechanisms of Tobacco Smoking Effects on Food Intake and Weight Control.
Topics: Animals; Arcuate Nucleus of Hypothalamus; Body Weight; Eating; Humans; Leptin; Neuropeptide Y; Nicotine; Receptors, Nicotinic; Tobacco Smoking | 2018 |
49 other study(ies) available for nicotine and neuropeptide y
| Article | Year |
|---|---|
Nicotine- and capsaicin-, but not potassium-evoked CGP-release from cultured guinea-pig spinal ganglia is inhibited by Ruthenium red.
Topics: Animals; Calcitonin Gene-Related Peptide; Calcium; Capsaicin; Cells, Cultured; Depression, Chemical; Ganglia, Spinal; Guinea Pigs; Neuropeptide Y; Nicotine; Norepinephrine; Potassium; Ruthenium Red; Secretory Rate | 1992 |
Release of CGRP-like immunoreactivity from cultured sensory neurons.
Topics: Animals; Calcitonin Gene-Related Peptide; Calcium; Capsaicin; Cells, Cultured; Ganglia, Spinal; Guinea Pigs; Neurons, Afferent; Neuropeptide Y; Nicotine; Norepinephrine; Potassium; Radioimmunoassay; Ruthenium Red | 1992 |
Neuropeptide Y in the rabbit maxillary sinus modulates cholinergic acceleration of mucociliary activity.
Topics: Animals; Cholinergic Fibers; Dose-Response Relationship, Drug; Female; Fluorescent Antibody Technique; Ganglia, Parasympathetic; Male; Maxillary Sinus; Methacholine Chloride; Mucociliary Clearance; Mucous Membrane; Neuropeptide Y; Nicotine; Rabbits; Sympathetic Nervous System | 1992 |
Nicotine-induced release of noradrenaline and neuropeptide Y in guinea-pig heart: role of calcium channels and protein kinase C.
Topics: Animals; Calcium Channels; Chromatography, High Pressure Liquid; Felodipine; Guinea Pigs; Heart; Myocardium; Neuropeptide Y; Nicotine; Norepinephrine; Protein Kinase C | 1991 |
Ruthenium-red inhibits CGRP release by capsaicin and resiniferatoxin but not by ouabain, bradykinin or nicotine in guinea-pig heart: correlation with effects on cardiac contractility.
Topics: Animals; Bradykinin; Calcitonin Gene-Related Peptide; Capsaicin; Diterpenes; Guinea Pigs; Myocardial Contraction; Myocardium; Neuropeptide Y; Nicotine; Ouabain; Ruthenium Red | 1991 |
Stimulation of rat adrenal medulla can induce differential changes in the peptide and mRNA levels of chromogranins, neuropeptides and other constituents of chromaffin granules.
Topics: Adrenal Medulla; Animals; Brain Chemistry; Carboxypeptidase H; Carboxypeptidases; Chromaffin Granules; Chromogranin A; Chromogranins; Cytochrome b Group; Dopamine beta-Hydroxylase; Male; Membrane Proteins; Nerve Tissue Proteins; Neuropeptide Y; Nicotine; Oxotremorine; Proteins; Rats; Rats, Inbred Strains; RNA, Messenger; Synaptophysin | 1991 |
Differential release of calcitonin gene-related peptide and neuropeptide Y from the isolated heart by capsaicin, ischaemia, nicotine, bradykinin and ouabain.
Topics: Animals; Bradykinin; Calcitonin Gene-Related Peptide; Capsaicin; Coronary Circulation; Guinea Pigs; Heart; Ischemia; Neuropeptide Y; Neuropeptides; Nicotine; Ouabain; Sensory Receptor Cells | 1989 |
Stimulation of cholinergic receptor mediated secretion from the bovine adrenal medulla by neuropeptide Y.
Topics: Acetylcholine; Adrenal Medulla; Animals; Cattle; Dimethylphenylpiperazinium Iodide; Enkephalins; Epinephrine; In Vitro Techniques; Neuropeptide Y; Nicotine; Norepinephrine; Radioimmunoassay; Receptors, Cholinergic | 1989 |
Nicotine-induced release of noradrenaline and neuropeptide Y in guinea pig heart.
Topics: Animals; Arousal; Dose-Response Relationship, Drug; Guinea Pigs; Male; Myocardium; Neuropeptide Y; Nicotine; Norepinephrine; Sympathetic Nervous System | 1988 |
Neuropeptide Y inhibits the nicotine-mediated release of catecholamines from bovine adrenal chromaffin cells.
Topics: Adrenal Glands; Animals; Binding Sites; Catecholamines; Cattle; Cells, Cultured; Chromaffin Granules; Chromaffin System; Kinetics; Neuropeptide Y; Nicotine | 1988 |
Nicotine elicits changes in expression of adrenal catecholamine biosynthetic enzymes, neuropeptide Y and immediate early genes by injection but not continuous administration.
Topics: Adrenal Glands; Animals; Catecholamines; Dopamine beta-Hydroxylase; Drug Administration Schedule; Gene Expression Regulation, Enzymologic; Infusion Pumps, Implantable; Injections, Subcutaneous; Male; Neuropeptide Y; Nicotine; Rats; Rats, Sprague-Dawley; Sympathetic Nervous System; Transcription, Genetic; Tyrosine 3-Monooxygenase | 1995 |
Inhibition of nicotinic acetylcholine receptor channels in bovine adrenal chromaffin cells by Y3-type neuropeptide Y receptors via the adenylate cyclase/protein kinase A system.
Topics: Acetylcholine; Adenylyl Cyclases; Animals; Calcium Channels; Cattle; Cells, Cultured; Chromaffin System; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Electrophysiology; Ion Channels; Neuropeptide Y; Nicotine; Nicotinic Antagonists; Patch-Clamp Techniques; Phosphorylation; Receptors, Neuropeptide Y | 1995 |
Neuropeptide modulation of cardiac intrinsic nerve activity: neuropeptide Y--a preliminary report.
Topics: Acetylcholine; Animals; Atrial Function; Dogs; Heart; Heart Atria; In Vitro Techniques; Isometric Contraction; Neuropeptide Y; Nicotine | 1994 |
Effects of differentiation on neuropeptide-Y receptors and responses in rat pheochromocytoma cells.
Topics: Adrenal Gland Neoplasms; Animals; Binding, Competitive; Cell Differentiation; Cell Division; Colforsin; Cyclic AMP; Dose-Response Relationship, Drug; Kinetics; Nerve Growth Factors; Neurons; Neuropeptide Y; Nicotine; PC12 Cells; Peptide Fragments; Pheochromocytoma; Potassium Chloride; Rats; Receptors, Neuropeptide Y | 1994 |
Antiserum against neuropeptide Y enhances the nicotine-mediated release of catecholamines from cultured rat adrenal chromaffin cells.
Topics: Adrenal Glands; Animals; Cells, Cultured; Chromaffin System; Epinephrine; Immune Sera; Neuropeptide Y; Nicotine; Norepinephrine; Rats | 1993 |
Nicotine-induced exocytotic norepinephrine release in guinea-pig heart, human atrium and bovine adrenal chromaffin cells: modulation by single components of ischaemia.
Topics: Adrenal Medulla; Animals; Calcium; Cattle; Cyanides; Dose-Response Relationship, Drug; Exocytosis; Fluorescent Dyes; Fura-2; Glucose; Guinea Pigs; Heart; Heart Atria; Hexamethonium; Humans; Hypoxia; In Vitro Techniques; Ischemia; Kinetics; Myocardial Ischemia; Myocardium; Neuropeptide Y; Nicotine; Norepinephrine | 1995 |
Nicotine administration reduces neuropeptide Y and neuropeptide Y mRNA concentrations in the rat hypothalamus: NPY may mediate nicotine's effects on energy balance.
Topics: Animals; Arcuate Nucleus of Hypothalamus; Blood Glucose; Corticosterone; Energy Metabolism; Hypothalamus; Insulin; Male; Neuropeptide Y; Nicotine; Osmolar Concentration; Paraventricular Hypothalamic Nucleus; Rats; Rats, Wistar; RNA, Messenger; Time Factors | 1995 |
Expression of catecholamine-synthesizing enzymes, peptidylglycine alpha-amidating monooxygenase, and neuropeptide Y mRNA in the rat adrenal medulla after acute systemic nicotine.
Topics: Adrenal Medulla; Animals; Catecholamines; Ganglionic Stimulants; Gene Expression Regulation, Enzymologic; In Situ Hybridization; Male; Mixed Function Oxygenases; Multienzyme Complexes; Neuropeptide Y; Nicotine; Protein Processing, Post-Translational; Rats; Rats, Sprague-Dawley; RNA, Messenger | 1997 |
Nicotine activates NPY and catecholaminergic neurons in brainstem regions involved in ACTH secretion.
Topics: Adrenocorticotropic Hormone; Animals; Brain Stem; Catecholamines; Dose-Response Relationship, Drug; Immunohistochemistry; Male; Neurons; Neuropeptide Y; Nicotine; Rats | 1997 |
Elevated neuropeptide Y gene expression and release during hypoglycemic stress.
Topics: Adrenal Medulla; Animals; Denervation; Gene Expression Regulation; Hypertension; Hypoglycemia; Hypoglycemic Agents; Insulin; Male; Neuropeptide Y; Nicotine; Nicotinic Agonists; Rats; Rats, Sprague-Dawley; Stress, Physiological; Superior Cervical Ganglion | 1997 |
Neuropeptide Y inhibits chromaffin cell nicotinic receptor-stimulated tyrosine hydroxylase activity through a receptor-linked G protein-mediated process.
Topics: Animals; Cattle; Cells, Cultured; Chromaffin Cells; Enzyme Inhibitors; Epinephrine; GTP-Binding Proteins; Kinetics; Neuropeptide Y; Nicotine; Nicotinic Agonists; Norepinephrine; Pertussis Toxin; Phosphorylation; Precipitin Tests; Receptors, Nicotinic; Stimulation, Chemical; Tyrosine 3-Monooxygenase; Virulence Factors, Bordetella | 1997 |
Three different vasoactive responses of rat tail artery to nicotine.
Topics: Animals; Arteries; Calcium Channels, L-Type; Dose-Response Relationship, Drug; In Vitro Techniques; Male; Neuropeptide Y; Nicotine; Rats; Rats, Sprague-Dawley; Tail; Vasoconstriction | 2000 |
Nicotine administration enhances NPY expression in the rat hypothalamus.
Topics: Animals; Body Weight; Dose-Response Relationship, Drug; Eating; Gene Expression; Hypothalamus; Male; Neuropeptide Y; Nicotine; Nicotinic Agonists; Rats; Rats, Sprague-Dawley; RNA, Messenger | 2000 |
Chronic maternal nicotine exposure alters neuronal systems in the arcuate nucleus that regulate feeding behavior in the newborn rhesus macaque.
Topics: Animals; Animals, Newborn; Arcuate Nucleus of Hypothalamus; Body Weight; Embryonic and Fetal Development; Feeding Behavior; Female; Gestational Age; Hydrocortisone; Image Processing, Computer-Assisted; In Situ Hybridization; Leptin; Macaca mulatta; Neurons; Neuropeptide Y; Nicotine; Pregnancy; Pro-Opiomelanocortin; RNA, Messenger | 2001 |
NPY regulates catecholamine secretion from human adrenal chromaffin cells.
Topics: Adolescent; Adrenal Glands; Adult; Catecholamines; Cells, Cultured; Child; Chromaffin Cells; Female; Humans; Male; Middle Aged; Neuropeptide Y; Nicotine; Peptide YY; Receptors, Neuropeptide Y; Signal Transduction | 2001 |
Nicotine and its withdrawal alter feeding induced by paraventricular hypothalamic injections of neuropeptide Y in Sprague-Dawley rats.
Topics: Animals; Body Weight; Dose-Response Relationship, Drug; Eating; Feeding Behavior; Female; Injections, Intraventricular; Neuropeptide Y; Nicotine; Nicotinic Agonists; Paraventricular Hypothalamic Nucleus; Rats; Rats, Sprague-Dawley; Substance Withdrawal Syndrome | 2002 |
Catecholamine and neuropeptide Y secretion from human adrenal chromaffin cells: effect of nicotine and KCl.
Topics: Catecholamines; Cells, Cultured; Chromaffin Cells; Enzyme-Linked Immunosorbent Assay; Humans; Neuropeptide Y; Nicotine; Nicotinic Agonists; Perfusion; Potassium Chloride | 2002 |
Nicotine administration decreases neuropeptide Y expression and increases leptin receptor expression in the hypothalamus of food-deprived rats.
Topics: Animals; Arcuate Nucleus of Hypothalamus; Food Deprivation; Gene Expression Regulation; Hypothalamus; Immunohistochemistry; Male; Neuropeptide Y; Nicotine; Nicotinic Agonists; Paraventricular Hypothalamic Nucleus; Rats; Rats, Sprague-Dawley; Receptors, Cell Surface; Receptors, Leptin | 2003 |
Neuropeptide Y secretion from bovine chromaffin cells inhibits cyclic AMP accumulation.
Topics: Animals; Arginine; Cattle; Cells, Cultured; Chromaffin Cells; Chromatography, High Pressure Liquid; Colforsin; Culture Media, Conditioned; Cyclic AMP; In Vitro Techniques; Neuropeptide Y; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Pertussis Toxin; Radioimmunoassay; Receptors, Neuropeptide Y | 2000 |
Effect of short-term cigarette smoke exposure on body weight, appetite and brain neuropeptide Y in mice.
Topics: Adipose Tissue; Animals; Appetite Regulation; Body Weight; Brain; Carrier Proteins; Disease Models, Animal; Down-Regulation; Drug Administration Schedule; Energy Metabolism; Hypothalamus; Ion Channels; Leptin; Male; Membrane Proteins; Mice; Mice, Inbred BALB C; Mitochondrial Proteins; Neuropeptide Y; Nicotine; RNA, Messenger; Smoking; Time Factors; Tobacco Use Disorder; Tumor Necrosis Factor-alpha; Uncoupling Protein 1; Uncoupling Protein 3 | 2005 |
Increased CRF-like and NPY-like immunoreactivity in adult rats exposed to nicotine during adolescence: relation to anxiety-like and depressive-like behavior.
Topics: Age Factors; Animals; Antibodies; Anxiety; Corticotropin-Releasing Hormone; Depression; Immunohistochemistry; Male; Maze Learning; Neuropeptide Y; Neurosecretory Systems; Nicotine; Nicotinic Agonists; Rats; Rats, Sprague-Dawley; Swimming | 2005 |
The chromogranin A fragment catestatin: specificity, potency and mechanism to inhibit exocytotic secretion of multiple catecholamine storage vesicle co-transmitters.
Topics: Adenosine Triphosphate; Animals; Catecholamines; Cell Culture Techniques; Chromaffin Cells; Chromogranin A; Chromogranins; Culture Media; Dopamine; Drug Interactions; Epinephrine; Exocytosis; Humans; Models, Biological; Neuropeptide Y; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Norepinephrine; PC12 Cells; Peptide Fragments; Rats; Reference Standards | 2006 |
Nicotine withdrawal increases body weight, neuropeptide Y and Agouti-related protein expression in the hypothalamus and decreases uncoupling protein-3 expression in the brown adipose tissue in high-fat fed mice.
Topics: Adipose Tissue, Brown; Agouti Signaling Protein; Agouti-Related Protein; Analysis of Variance; Animals; Body Weight; Dietary Fats; Hypothalamus; Intercellular Signaling Peptides and Proteins; Ion Channels; Male; Mice; Mice, Inbred C57BL; Mitochondrial Proteins; Neuropeptide Y; Nicotine; Nicotinic Agonists; Receptors, Adrenergic, beta; Substance Withdrawal Syndrome; Uncoupling Protein 3 | 2007 |
Nicotine regulates mRNA expression of feeding peptides in the arcuate nucleus in neonatal rat pups.
Topics: Age Factors; Agouti-Related Protein; Animals; Animals, Newborn; Arcuate Nucleus of Hypothalamus; Autoradiography; Body Weight; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Female; Gene Expression; In Situ Hybridization; Intercellular Signaling Peptides and Proteins; Leptin; Neuropeptide Y; Nicotine; Nicotinic Agonists; Pregnancy; Pro-Opiomelanocortin; Protein Binding; Rats; Rats, Sprague-Dawley; RNA, Messenger | 2007 |
Effect of acupuncture on anxiety-like behavior during nicotine withdrawal and relevant mechanisms.
Topics: Acupuncture; Amygdala; Analysis of Variance; Animals; Anxiety; Behavior, Animal; Corticotropin-Releasing Hormone; Disease Models, Animal; Male; Maze Learning; Motor Activity; Neuropeptide Y; Nicotine; Rats; Rats, Sprague-Dawley; Substance Withdrawal Syndrome | 2008 |
Effects of NPY and the specific Y1 receptor agonist [D-His(26)]-NPY on the deficit in brain reward function and somatic signs associated with nicotine withdrawal in rats.
Topics: Animals; Arginine; Brain; Drug Implants; Electric Stimulation; Electrodes, Implanted; Male; Neuropeptide Y; Nicotine; Nicotinic Agonists; Rats; Rats, Wistar; Receptors, G-Protein-Coupled; Receptors, Neuropeptide; Reward; Self Stimulation; Substance Withdrawal Syndrome | 2008 |
Involvement of neuropeptide Y Y(1) receptors in the acute, chronic and withdrawal effects of nicotine on feeding and body weight in rats.
Topics: Animals; Arginine; Body Weight; Dose-Response Relationship, Drug; Drug Combinations; Eating; Fluorescent Antibody Technique, Indirect; Immunohistochemistry; Injections, Intraventricular; Male; Microinjections; Neuropeptide Y; Nicotine; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide Y; Substance Withdrawal Syndrome; Time Factors | 2009 |
Vulnerability to nicotine abstinence-related social anxiety-like behavior: molecular correlates in neuropeptide Y, Y2 receptor and corticotropin releasing factor.
Topics: Amygdala; Animals; Anxiety; CA1 Region, Hippocampal; Conditioning, Operant; Corticotropin-Releasing Hormone; Disease Models, Animal; Dose-Response Relationship, Drug; Locomotion; Male; Neuropeptide Y; Nicotine; Nicotinic Agonists; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide Y; RNA, Messenger; Tobacco Use Disorder | 2011 |
Effects of a selective Y2R antagonist, JNJ-31020028, on nicotine abstinence-related social anxiety-like behavior, neuropeptide Y and corticotropin releasing factor mRNA levels in the novelty-seeking phenotype.
Topics: Amygdala; Animals; Anxiety; Benzamides; CA3 Region, Hippocampal; Corticosterone; Corticotropin-Releasing Hormone; Disease Models, Animal; Exploratory Behavior; Interpersonal Relations; Male; Motor Activity; Neuropeptide Y; Nicotine; Phenotype; Piperazines; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide Y; RNA, Messenger; Substance Withdrawal Syndrome | 2011 |
Nicotine excites hypothalamic arcuate anorexigenic proopiomelanocortin neurons and orexigenic neuropeptide Y neurons: similarities and differences.
Topics: Action Potentials; Animals; Appetite Depressants; Arcuate Nucleus of Hypothalamus; Intracellular Signaling Peptides and Proteins; Mice; Mice, Transgenic; Neurons; Neuropeptide Y; Neuropeptides; Nicotine; Orexins; Pro-Opiomelanocortin | 2011 |
Nicotine evoked improvement in learning and memory is mediated through NPY Y1 receptors in rat model of Alzheimer's disease.
Topics: Alzheimer Disease; Amygdala; Analysis of Variance; Animals; Arcuate Nucleus of Hypothalamus; Arginine; Colchicine; Dentate Gyrus; Disease Models, Animal; Escape Reaction; Learning; Male; Maze Learning; Memory; Neuropeptide Y; Nicotine; Nicotinic Agonists; Nucleus Accumbens; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide Y; Septal Nuclei | 2012 |
Nicotine induces negative energy balance through hypothalamic AMP-activated protein kinase.
Topics: Adipose Tissue, Brown; AMP-Activated Protein Kinases; Animals; Appetite; Eating; Energy Metabolism; Gene Expression Regulation; Hypothalamus; Male; Motor Activity; Neuropeptide Y; Nicotine; Pro-Opiomelanocortin; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic; Temazepam; Thermogenesis | 2012 |
Nicotine-induced anxiety-like behavior in a rat model of the novelty-seeking phenotype is associated with long-lasting neuropeptidergic and neuroplastic adaptations in the amygdala: effects of the cannabinoid receptor 1 antagonist AM251.
Topics: Aging; Amygdala; Animals; Anxiety; Brain-Derived Neurotrophic Factor; Corticotropin-Releasing Hormone; Exploratory Behavior; In Situ Hybridization; Interpersonal Relations; Male; Microfilament Proteins; Motor Activity; Nerve Tissue Proteins; Neuronal Plasticity; Neuropeptide Y; Neuropeptides; Nicotine; Nicotinic Agonists; Phenotype; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Substance Withdrawal Syndrome | 2012 |
Enhanced nicotine-seeking behavior following pre-exposure to repeated cocaine is accompanied by changes in BDNF in the nucleus accumbens of rats.
Topics: Animals; Brain-Derived Neurotrophic Factor; Cocaine; Dynorphins; Gene Expression; Male; Motor Activity; Neuropeptide Y; Nicotine; Nucleus Accumbens; Rats; Rats, Wistar; Receptor, trkB; Receptors, Corticotropin-Releasing Hormone; Receptors, Opioid, mu; Risk Factors; Self Administration; Tobacco Use Disorder | 2013 |
Beta-amyloid peptides undergo regulated co-secretion with neuropeptide and catecholamine neurotransmitters.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Amyloid Precursor Protein Secretases; Animals; Catecholamines; Cattle; Cells, Cultured; Chromaffin Cells; Colforsin; Cyclic AMP; Dopamine; Enkephalins; Epinephrine; Galanin; Ganglionic Stimulants; Humans; Neuroblastoma; Neurons; Neuropeptide Y; Neuropeptides; Neurotransmitter Agents; Nicotine; Norepinephrine; Peptide Fragments; Secretory Vesicles | 2013 |
Agmatine attenuates nicotine induced conditioned place preference in mice through modulation of neuropeptide Y system.
Topics: Agmatine; Animals; Brain; Conditioning, Psychological; Drug Interactions; Male; Mice; Motor Activity; Neuropeptide Y; Nicotine; Nicotinic Agonists | 2014 |
HCN hyperpolarization-activated cation channels strengthen virtual nicotinic EPSPs and thereby elevate synaptic amplification in rat sympathetic neurons.
Topics: Animals; Biophysical Phenomena; Biophysics; Electric Stimulation; Excitatory Postsynaptic Potentials; Female; Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels; Male; Neurons; Neuropeptide Y; Nicotine; Patch-Clamp Techniques; Pyrimidines; Rats; Rats, Sprague-Dawley; RNA, Messenger; Superior Cervical Ganglion; Synapses; User-Computer Interface | 2016 |
A combination of dietary fat intake and nicotine exposure enhances CB1 endocannabinoid receptor expression in hypothalamic nuclei in male mice.
Topics: Animals; Arcuate Nucleus of Hypothalamus; Body Weight; Diet, High-Fat; Dorsomedial Hypothalamic Nucleus; Eating; Hypothalamic Area, Lateral; Male; Mice; Microdissection; Neuropeptide Y; Nicotine; Paraventricular Hypothalamic Nucleus; Receptor, Cannabinoid, CB1; Receptors, Corticotropin-Releasing Hormone | 2020 |
Chronic oral nicotine administration and withdrawal regulate the expression of neuropeptide Y and its receptors in the mesocorticolimbic system.
Topics: Administration, Oral; Animals; Behavior, Animal; Limbic System; Male; Mesencephalon; Motor Activity; Neuropeptide Y; Nicotine; Nicotinic Agonists; Prefrontal Cortex; Rats; Rats, Wistar; Receptors, Neuropeptide Y; RNA, Messenger; Substance Withdrawal Syndrome | 2021 |